Do stimulation characteristics of the first in vitro fertilization cycle predict pregnancy in women of 40 years old and over?

Fertility and Sterility

Volumn 91, Issue 4 SUPPL., 2009, Pages 1311-1313

  Homburg, Roy ^a   Meltcer, Simion ^a   Rabinson, Jacob ^a   Zohav, Efraim ^a   Anteby, Eyal Y ^a   Orvieto, Raoul ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN; GONADORELIN ANTAGONIST; GONADOTROPIN DERIVATIVE;

AGE DISTRIBUTION; ARTICLE; FERTILIZATION IN VITRO; HUMAN; MATERNAL AGE; OBSTETRIC CARE; OVARIAN RESERVE; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGE FACTORS; ESTROGENS; FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; HUMANS; MENSTRUAL CYCLE; MIDDLE AGED; OOCYTE RETRIEVAL; OVULATION INDUCTION; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY RATE; PROGESTERONE; PROSPECTIVE STUDIES;

EID: 63249093273     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.01.094     Document Type: Article

References (9)

1. Elizur S.E., Lerner-Geva L., Levron J., Shulman A., Bider D., and Dor J. Factors predicting in-vitro fertilization treatment outcome: a multivariate analysis of 5310 cycles. RBM Online 10 (2005) 645-649
2. Broekmans F.J., Kwee J., Hendriks D.J., Mol B.W., and Lambalk C.B. A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update 12 (2006) 685-718
3. Bancsi L.F., Broekmans F.J., Mol B.W., Habbema J.D., and te Velde E.R. Performance of basal follicle-stimulating hormone in the prediction of poor ovarian response and failure to become pregnant after in-vitro fertilization: a meta-analysis. Fertil Steril 79 (2003) 1091-1100
4. Klinkert E.R., Broekmans F.J., Loorman C.W., Habbema J.D., and te Velde E.R. The antral follicle count is a better marker than basal follicle-stimulating hormone for the selection of older patients with acceptable pregnancy prospects after in-vitro fertilization. Fertil Steril 83 (2005) 811-814
5. van Rooij I.A., Broekmans F.J., te Velde E.R., Fauser B.C., Bancsi L.F., de Jong F.H., and Themmen A.P. Serum anti-mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17 (2002) 3065-3071
6. Kwee J., Schats R., McDonnell J., Schoemaker J., and Lambalk C.B. The clomiphene citrate challenge test (CCCT) versus the exogenous follicle-stimulating hormone ovarian reserve test (EFOET) as single test for identification of low and hyperresponders to in-vitro fertilization (IVF). Fertil Steril 85 (2006) 1714-1722
7. Mol B.W., Verhagen T.E., Hendriks D.J., Collins J.A., Coomarasamy A., Opmeer B.C., and Broekmans F.J. Value of ovarian reserve testing before IVF: a clinical decision analysis. Hum Reprod 21 (2006) 1816-1823
8. Gleicher N., and Barad D. Unexplained infertility: does it really exist?. Hum Reprod 21 (2006) 1951-1955
9. Orvieto R., Bar-Hava I., Yoeli R., Ashkenazi J., Rabinerson D., Bar J., and Fisch B. Results of in vitro fertilization in women aged 43-45 years. Gynecol Endocrinol 18 (2004) 75-78